Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients
A Pilot Study in Cancer Patients With Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in the Upper Extremity Treated With Low Molecular Weight Heparin (LMWH) and Apixaban (Catheter 3)
Sponsor: Jewish General Hospital
This observational or N/A phase trial investigates Cancer Patients and Central Venous Catheter Thrombosis and is currently ongoing. Jewish General Hospital leads this study, which shows 13 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
Apr 2025 — Present [monthly]
Unknown
-
Jan 2025 — Apr 2025 [monthly]
Unknown
-
Sep 2024 — Jan 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Aug 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 8 earlier versions
-
Sep 2021 — Aug 2023 [monthly]
Recruiting
-
Mar 2021 — Sep 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Mar 2019 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Jewish General Hospital
- Michael Kovacs
- Ottawa Hospital Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .